newsMany people may not receive a COVID-19 vaccine until 202216 December 2020 | By Hannah Balfour (European Pharmaceutical Review)Studies show that more than a fifth of the global population, mostly in low- and middle-income countries, may have to wait until at least 2022 to receive a COVID-19 vaccine.
newsReport shows US brand-name drug prices ‘highest in the world’7 May 2019 | By European Pharmaceutical ReviewA new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.
newsInadequate FDA oversight concerning fentanyl prescriptions19 February 2019 | By European Pharmaceutical ReviewA study has found that the FDA failed to design and implement an effective monitoring program for Transmucosal Immediate-Release Fentanyls...
newsRotavirus vaccine cuts infant diarrhoea deaths in Malawi15 August 2018 | By European Pharmaceutical Review"The key message of this paper is that to do the best by all our children and to help them survive, all countries should introduce rotavirus vaccination.”
newsBlood-based epigenetic may hold clues to autism24 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Epigenetic data reveals immune-response pathways that may prove critical to understanding autism...
newsA path toward ending AIDS epidemic in the US by 202515 May 2017 | By Niamh Marriott, Junior EditorA new study describes an ambitious but feasible path toward what may have seemed unachievable just a decade ago: an end to the AIDS epidemic in the US...
newsThe global cost of norovirus26 April 2016 | By Victoria White, Digital Content ProducerNorovirus results in roughly $4.2 billion in health care costs and $60.3 billion in societal costs annually, a new study has found...
